SHH and non-small cell lung carcinoma: The authors also analyzed the expression of Gli1 by immunohistochemistry in a panel of 120 samples of NSCLC in a tissue microarray and found that 87% of adenocarcinomas and 93% of squamous cell carcinoma demonstrated Shh pathway activation.